Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development - Possible application for a model to detect co-modifiers of carcinogenesis

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 25-32

  Imai, Toshio ^a   Cho, Young Man ^a   Hasumura, Mai ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

7,12 Dimethylbenz(a)anthracene; Acrylamide; Mammary carcinogenesis; Medium term model; N methyl N nitrosourea; Rat

Indexed keywords

ACRYLAMIDE; BIS(2 HYDROXYPROPYL)NITROSAMINE; DIMETHYLBENZ[A]ANTHRACENE; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST FIBROADENOMA; BREAST FIBROMA; BREAST TUMOR; CANCER LOCALIZATION; CANCER MODEL; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR LOCALIZATION; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ACRYLAMIDE; ADMINISTRATION, ORAL; ALKYLATING AGENTS; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; NITROSAMINES; RATS; RATS, SPRAGUE-DAWLEY; THYROID NEOPLASMS;

EID: 27144447733     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.019     Document Type: Article

References (35)

1. C.J. Smith, T.A. Perfetti, M.A. Rumple, A. Rodgman, and D.J. Doolittle 'IARC group 2A Carcinogens' reported in cigarette mainstream smoke Food Chem. Toxicol. 38 2000 371 383
2. The International Agency for Research on Cancer (IARC) Working Group on the evaluation of carcinogenic risks to humans - some industrial chemicals, Acrylamide, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 60, IARC, Lyon, 1994, pp. 389-433.
3. E. Bergmark Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers Chem. Res. Toxicol. 10 1997 78 84
4. E. Tareke, P. Rydberg, P. Karlsson, S. Eriksson, and M. Tornqvist Analysis of acrylamide, a carcinogen formed in heated foodstuffs J. Agric. Food Chem. 50 2002 4998 5006
5. S. Takatsuki, S. Nemoto, K. Sasaki, and T. Maitani Determination of acrylamide in processed foods by LC/MS using column switching Shokuhin Eiseigaku Zasshi 44 2003 89 95
6. M. Jezussek, and P. Schieberle A new LC/MS-method for the quantitation of acrylamide based on a stable isotope dilution assay and derivatization with 2-mercaptobenzoic acid. Comparison with two GC/MS methods J. Agric. Food Chem. 51 2003 7866 7871
7. J.S. Ahn, L. Castle, D.B. Clarke, A.S. Lloyd, M.R. Philo, and D.R. Speck Verification of the findings of acrylamide in heated foods Food Addit. Contam. 19 2002 1116 1124
8. J.A. Roach, D. Andrzejewski, M.L. Gay, D. Nortrup, and S.M. Musser Rugged LC-MS/MS survey analysis for acrylamide in foods J. Agric. Food Chem. 51 2003 7547 7554
9. A. Becalski, B.P. Lau, D. Lewis, and S.W. Seaman Acrylamide in foods: occurrence, sources, and modeling J. Agric. Food Chem. 51 2003 802 808
10. K.M. Crofton, S. Padilla, H.A. Tilson, D.C. Anthony, J.H. Raymer, and R.C. MacPhail The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects Toxicol. Appl. Pharmacol. 139 1996 163 176
11. E.J. Lehning, A. Persaud, K.R. Dyer, B.S. Jortner, and R.M. LoPachin Biochemical and morphologic characterization of acrylamide peripheral neuropathy Toxicol. Appl. Pharmacol. 151 1998 211 221
12. D.W. Sickles, J.D. Stone, and M.A. Friedman Fast axonal transport: a site of acrylamide neurotoxicity? Neurotoxicology 23 2002 223 251
13. R.W. Tyl, and M.A. Friedman Effects of acrylamide on rodent reproductive performance Reprod. Toxicol. 17 2003 1 13
14. L. Abramsson-Zetterberg The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay Mutat. Res. 535 2003 215 222
15. K.L. Dearfield, G.R. Douglas, U.H. Ehling, M.M. Moore, G.A. Sega, and D.J. Brusick Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk Mutat. Res. 330 1995 71 99
16. R.J. Bull, M. Robinson, R.D. Laurie, G.D. Stoner, E. Greisiger, J.R. Meier, and J. Stober Carcinogenic effects of acrylamide in Sencar and A/J mice Cancer Res. 44 1984 107 111
17. R.J. Bull, M. Robinson, and J.A. Stober Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice Cancer Lett. 24 1984 209 212
18. M.A. Friedman, L.H. Dulak, and M.A. Stedham A lifetime oncogenicity study in rats with acrylamide Fundam. Appl. Toxicol. 27 1995 95 105
19. K.A. Johnson, S.J. Gorzinski, K.M. Bodner, R.A. Campbell, C.H. Wolf, M.A. Friedman, and R.W. Mast Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats Toxicol. Appl. Pharmacol. 85 1986 154 168
20. K. Fujita, T. Ohnishi, K. Sekine, M. Iigo, and H. Tsuda Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats Jpn. J. Cancer Res. 93 2002 616 625
21. M. Hirose, S. Takahashi, K. Ogawa, M. Futakuchi, T. Shirai, and M. Shibutani Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats Cancer Lett. 143 1999 173 178
22. K. Imaida, M. Sano, S. Tamano, M. Asamoto, K. Ogawa, M. Futakuchi, and T. Shirai Organ dependent enhancement of rat 3,2′-dimethyl-4-aminobiphenyl (DMAB) carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): positive effects on the intestine but not the prostate Carcinogenesis 22 2001 1295 1299
23. K. Ogawa, S. Iwasaki, H. Esumi, S. Fukushima, and T. Shirai Modification by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) of 3,2′-dimethyl-4-aminobiphenyl (DMAB)-induced rat pancreatic and intestinal tumorigenesis Cancer Lett. 124 1998 31 37
24. L.C. VanderPloeg, D.M. Wolfrom, and C.W. Welsch Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea Cancer Res. 51 1991 3399 3404
25. C.W. Welsch Caffeine and the development of the normal and neoplastic mammary gland Proc. Soc. Exp. Biol. Med. 207 1994 1 12
26. C.D. Allred, K.F. Allred, Y.H. Ju, L.M. Clausen, D.R. Doerge, and S.L. Schantz Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats Carcinogenesis 25 2004 211 218
27. D. Gallo, G. Ferrandina, S. Giacomelli, E. Fruscella, G. Zannoni, and P. Morazzoni Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors Cancer Lett. 186 2002 43 48
28. A.R. Tagliaferro, A.M. Ronan, L.D. Meeker, H.J. Thompson, and A.L. Scott Cyclic food restriction, insulin and mammary cell proliferation in the rat Carcinogenesis 18 1997 2271 2276
29. K. Kito, T. Kihana, A. Sugita, S. Murao, S. Akehi, and M. Sato Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas Mol. Carcinog. 17 1996 78 83
30. M. Yu, D.Y. Ryu, and E.G. Snyderwine Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine Mol. Carcinog. 27 2000 76 83
31. J.D. Haag, G.M. Brasic, L.A. Shepel, M.A. Newton, C.J. Grubbs, and R.A. Lubet A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors Mol. Carcinog. 24 1999 47 56
32. T. Imai, J. Onose, M. Hasumura, M. Ueda, T. Takizawa, and M. Hirose Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation Toxicol. Pathol. 32 2004 229 236
33. Y. Hiasa, M. Ohshima, Y. Kitahori, T. Yuasa, T. Fujita, and C. Iwata Promoting effects of 3-amino-1,2,4-triazole on the development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine Carcinogenesis 3 1982 381 384
34. K. Yasuhara, T. Koujitani, K. Takegawa, M. Nasu, H. Onodera, and H. Takagi Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action Carcinogenesis 22 2001 613 618
35. N. Fujimoto, Y. Sakai, and A. Ito Increase in estrogen receptor levels in MNU-induced thyroid tumors in LE rats Carcinogenesis 13 1992 1315 1318